Literature DB >> 3508443

Virus-induced formation of reactive oxygen intermediates in phagocytic cells.

E Peterhans1, M Grob, T Bürge, R Zanoni.   

Abstract

Viruses cause disease by a wide variety of mechanisms. These include the impairment of differentiated host cell functions and the killing of infected cells. The latter is referred to as cytopathic effect and is exemplified by Polio virus infection where paralysis results from the loss of neurons killed by the virus. Host immune response as a factor contributing to disease is evident in the skin rashes in measles and rubella. Virus-immune complexes occur in many infections and may be associated with glomerulonephritis and arthropathy. We describe two mechanisms by which viruses activate the generation of reactive oxygen intermediates (ROI) in polymorphonuclear leukocytes. The first is mediated by antiviral antibody and hence is controlled by the immune system. The second mechanism depends on a direct interaction of viral antigen with the plasma membrane of the phagocyte. It is suggested that the direct activation of ROI generation by paramyxo- and influenza viruses may be related to their well-known toxic effects in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508443     DOI: 10.3109/10715768709069768

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  26 in total

1.  Perturbations in the antioxidant metabolism during Newcastle disease virus (NDV) infection in chicken : protective role of vitamin E.

Authors:  Kadiam C Venkata Subbaiah; D Raniprameela; Gopalareddygari Visweswari; Wudayagiri Rajendra; Valluru Lokanatha
Journal:  Naturwissenschaften       Date:  2011-10-18

2.  The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.

Authors:  Ryan D Michalek; S Troy Pellom; Beth C Holbrook; Jason M Grayson
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

3.  Genome-wide fitness profiling reveals adaptations required by Haemophilus in coinfection with influenza A virus in the murine lung.

Authors:  Sandy M Wong; Mariana Bernui; Hao Shen; Brian J Akerley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

4.  Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice.

Authors:  Yuichi Yageta; Yukio Ishii; Yuko Morishima; Hironori Masuko; Satoshi Ano; Tadahiro Yamadori; Ken Itoh; Kaoru Takeuchi; Masayuki Yamamoto; Nobuyuki Hizawa
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

5.  Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection.

Authors:  Pankaj Kumar; Sonal Sharma; MadhU Khanna; Hanumantharao Guru Raj
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

6.  Response and recovery in the plasma metabolome tracks the acute LCMV-induced immune response.

Authors:  William R Wikoff; Ewa Kalisak; Sunia Trauger; Marianne Manchester; Gary Siuzdak
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

7.  Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression.

Authors:  Mohammad Jamaluddin; Bing Tian; Istvan Boldogh; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

8.  Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.

Authors:  S Christen; E Peterhans; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.

Authors:  Juan A De La Cruz; Thota Ganesh; Becky A Diebold; Weiping Cao; Amelia Hofstetter; Neetu Singh; Amrita Kumar; James McCoy; Priya Ranjan; Susan M E Smith; Suryaprakash Sambhara; J David Lambeth; Shivaprakash Gangappa
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

10.  Oxidative stress and redox modulation potential in type 1 diabetes.

Authors:  Meghan M Delmastro; Jon D Piganelli
Journal:  Clin Dev Immunol       Date:  2011-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.